Funding Projections to Introduce Three New Family Planning Methods in India

April 2017
This publication was produced for review by the United States Agency for International Development.
It was prepared by Avenir Health for the Health Finance and Governance project.
FUNDING PROJECTIONS TO INTRODUCE
THREE NEW FAMILY PLANNING
METHODS IN INDIA

The Health Finance and Governance Project
USAID’s Health Finance and Governance (HFG) project will help to improve health in developing countries by
expanding people’s access to health care. Led by Abt Associates, the project team will work with partner countries
to increase their domestic resources for health, manage those precious resources more effectively, and make wise
purchasing decisions. As a result, this six-year, $209 million global project will increase the use of both primary and
priority health services, including HIV/AIDS, tuberculosis, malaria, and reproductive health services. Designed to
fundamentally strengthen health systems, HFG will support countries as they navigate the economic transitions
needed to achieve universal health care.
April 2017
Cooperative Agreement No: AID-OAA-A-12-00080
Submitted to: Scott Stewart, AOR
Office of Health Systems
Bureau for Global Health
Recommended Citation: Health Finance & Governance project. April 2017. Funding Projections to Introduce
Three New Family Planning Methods in India. Bethesda, MD: Health Finance & Governance project, Abt Associates
Inc.
Abt Associates Inc. | 4550 Montgomery Avenue, Suite 800 North | Bethesda, Maryland 20814
T: 301.347.5000 | F: 301.652.3916 | www.abtassociates.com
Avenir Health | Broad Branch Associates | Development Alternatives Inc. (DAI) |
| Johns Hopkins Bloomberg School of Public Health (JHSPH) | Results for Development Institute (R4D)
| RTI International | Training Resources Group, Inc. (TRG)

FUNDING PROJECTIONS
TO INTRODUCE
THREE NEW FAMILY PLANNING
METHODS IN INDIA
DISCLAIMER
The author’s views expressed in this publication do not necessarily reflect the views of the United States Agency
for International Development (USAID) or the United States Government.

i
CONTENTS
Acronyms................................................................................................................. iii
Executive Summary ................................................................................................ v
1. Introduction ......................................................................................................... 1
1.1 Background............................................................................................................................1
1.2 Problem Statement and Objectives................................................................................2
2. Methods ................................................................................................................ 3
2.1 Projections of mCPR and estimation of additional users over next five years ..3
2.2 Impact of introduction of new methods .......................................................................3
2.3 The number of total and additional users of modern contraception ...................3
2.4 Method mix among additional users for new methods ............................................4
2.5 Capacity Building..................................................................................................................5
3. Results................................................................................................................... 7
4. Conclusion.......................................................................................................... 13
Annex A: State-level Projections for Modern Methods Contraceptive Use
and Costs ................................................................................................................ 15
Annex B. Capacity Building of Staff for Introducing New Contraceptives... 47
List of Tables
Table ES.1: Annual and total cost of commodities and capacity building for new methods
2017-2021 (Rs. millions)........................................................................................................... vii
Table 1: Distribution of additional users by new methods.........................................................5
Table 2: Projected mCPR for calculating the users of modern methods...............................7
Table 3: Number of additional users of all methods in all states of India 2017–2021........9
Table 4: Users of new methods and OCPs 2017–2021 ............................................................10
Table 5: Commodities required per method per year and costs per method per year..10
Table 6: Total cost of new methods, 2017–2021 (RS. millions)..............................................11
Table 7: Total cost of training (Rs. millions).................................................................................11
Table 8: Annual and total cost of commodities and capacity building for new methods
2017-2021 (Rs. millions)...........................................................................................................12
Table A.1: Projections of mCPR during 2012-2020....................................................................16
Table A.2: Projected additional users for all methods during 2012-2020............................18
Table A.2: Projected additional users for all methods during 2012-2020 (Cont.).............20
Table A.3: mCPR and Method mix..................................................................................................22
Table A.4: Distribution of additional users by methods -Non-focus states and districts 24
Table A.4: Distribution of additional users by methods -Non-focus states and districts
(cont.)............................................................................................................................................26
Table A.5: Distribution of additional users by methods -Focus states and districts .........28
Table A.5: Distribution of additional users by methods -Focus states and districts
(Cont.)...........................................................................................................................................29
Table A.6: Projected number of users of injectable, OCP, Centchroman and POP-Non
Focus states and districts.........................................................................................................30

ii
Table A.6: Projected number of users of injectable, OCP, Centchroman and POP-Non
Focus states and districts (Cont.)..........................................................................................32
Table A.7: Projected number of users of injectable, OCP, Centchroman and POP-Focus
and N0n-Focus states and districts.......................................................................................34
Table A.7: Projected number of users of injectable, OCP, Centchroman and POP-Focus
and N0n-Focus states and districts (Cont.)........................................................................35
Table A.8: Total users of new methods-all states and districts...............................................36
Table A.9: Total requirement of commodities-all states...........................................................38
Table A.9: Total requirement of commodities-all states (Cont.)............................................40
Table A.10: Budget requirement of new contraceptives-all states.........................................42
Table A.10: Budget requirement of new contraceptives:-All states (Cont.) .......................44
Table A.11: Summary Cost of New Methods for 2017-2021..................................................46
Table B.1: Health Infrastructure in all states of India .................................................................47
Table B.2: State level courses (number of participants and states/UTs included) .............49
Table B.3: Cost of state level trainers ............................................................................................51
Table B.4: District level and CHC/PHC level courses required and their cost..................52
Table B.5: LHV and ANM courses required and their cost .....................................................54
List of Figures
Figure ES.1: Projected number of modern method users 2016-2021.................................... vi
Figure 1: Number of modern method users 2016–2021............................................................7

iii
ACRONYMS
AHS Annual Health Survey
ANM Auxiliary Nurse Midwife
ANMTC Auxiliary Nurse Midwife Training Centre
ASHA Accredited Social Health Activist
CHC Community Health Center
COC Combined Oral Contraceptive Pill
DLHS District Level Household Survey
DMPA Depot Medroxyprogesterone Acetate
FPET Family Planning Estimation Tool
GOI Government of India
HIV Human Immunodeficiency Virus
IUCD Intrauterine Contraceptive Devices
LHV Lady Health Visitor
mCPR Modern Method Contraceptive Prevalence Rate
MO Medical Officer
MWRA Married Women of Reproductive Age
NFHS National Family Health Survey
OBGYN Obstetrician and Gynecologist
OCP Oral Contraceptive Pill
PHC Primary Health Center
POP Progesterone-only Pill
PPIUCD Postpartum Intrauterine Contraceptive Device
SD Subdivision
STI Sexually Transmitted Infection
TFR Total Fertility Rate
USAID United States Agency for International Development

v
EXECUTIVE SUMMARY
Introduction
India has recently added three new family planning methods to the National Family Planning Programme:
(1) Depot Medroxyprogesterone Acetate (DMPA), an injectable contraceptive, (2) Centchroman, a
weekly oral contraceptive pill, and (3) a Progesterone-only Pill (POP). This public health policy change is
intended to accelerate progress under India’s Family Planning 2020 goals, which include providing
contraceptive coverage to an additional 48 million women and increasing contraceptive options. This
financing projection provides the Government of India with estimates of funding required to procure
these new contraceptives and ensure that proper budget supports effective implementation.
The USAID-funded Health Finance and Governance team applied a modelling tool to project state-wise
modern method contraceptive prevalence rates (mCPR) and new users over the next five years. The
projections include contraceptive method mix changes both for new users and switchers due to the
introduction of new contraceptives. Based on the method mix projections, this report estimates the
funding required by the government to procure and implement these three new contraceptive methods
over the five-year period.
Methods
Trends in the future use of modern contraception were projected based on the series of family planning
surveys conducted over the years (including National Family Health Survey, District Level Household
Survey, and Annual Health Survey) and the Family Planning Estimation Tool, a model for projecting
trends in modern contraceptive use. Projections were made at both the national and state level.
Family planning use in India is largely for limiting the total number of births. Female sterilization is the
dominant method. Spacing methods (pills, condoms, and traditional methods such as withdrawal) are
used infrequently and sporadically. International experience has shown that the addition of new methods
to a national program can increase contraceptive use significantly. Therefore, we assumed that the
addition of the three new methods will lead to an increase in overall modern contraceptive use,
primarily for spacing, while the use of permanent methods will continue according to current patterns.
We also assumed that the uptake of injectables will initially be slow but by 2021 half of additional users
will be using injectables and the other half will be using equal shares of combined oral contraceptive pills
(COCs), Centchroman, and POPs.
Capacity building of service providers is required at all levels before supplies of new methods start
arriving at the facilities. Three days of training are required for regional trainers to cover injectables,
Centchroman, POPs, COCs, and emergency contraceptive pills. Similar training is needed at the state
level and below. Training of trainers at the state level has begun and will be cascaded down to lower
levels in the coming three years.

vi
Results
The total number of modern method users increases from 128 million in 2016 to 150 million in 2021,
resulting in 22 million additional users of modern contraception (Figure ES.1).
Figure ES.1: Projected number of modern method users 2016-2021
Detailed projections by state and year for married women of reproductive age, mCPR, additional users
for all methods, and their method-wise break-up were also generated. We project that 17 states will
have mCPR above 60 percent by 2021. The amount of increase varies by state according to their
historical trends. The largest increases in mCPR are projected for Arunachal Pradesh, Bihar,
Chhattisgarh, Delhi, Gujarat, Himachal Pradesh, Jammu & Kashmir, Kerala, Meghalaya, Manipur, Sikkim,
Tamil Nadu, Uttar Pradesh, and West Bengal.
The largest number of additional new method users is projected to come from Uttar Pradesh followed
by West Bengal, Bihar, Madhya Pradesh, and Rajasthan. Except for West Bengal, these are all focus
states. Under the assumptions described above, there will be almost 230,000 users of injectables, and
76,000 users each of Centchroman and of POP by 2021. The remainder of the projected additional
users of modern contraceptives will use existing methods including sterilization, COC, and condoms.
115
120
125
130
135
140
145
150
155
2016 2017 2018 2019 2020 2021
Million
Years

vii
Table ES.1 summarizes the timing and costs of the new commodities and capacity building. The total
cost of commodities for the new methods is expected to be about Rs. 529 million from 2017 to 2021.
Capacity building adds an additional Rs. 321 million for a total additional cost of Rs. 850 million.
Expenditures are higher in the first three years while training is underway, but then drop once the scale-
up phase is complete.
Table ES.1: Annual and total cost of commodities and capacity building for new methods 2017-2021
(Rs. millions)
2017 2018 2019 2020 2021 2017-2021
Injectable 27 43 44 57 68 239
Centchroman 2 2 2 2 2 10
POP 76 78 69 57 280
Total 29 121 123 127 127 529
Cost of capacity
building
150 84 87 321
Total 179 205 211 128 127 850
Conclusion
The addition of these new methods to the government family planning program is intended to provide
better choices for couples who wish to space their births or do not want to use sterilization. It is
expected that the availability of these new methods will increase the number of modern method users
of family planning by improving choice and the quality of services. For the three new modern methods, it
is estimated that there will be almost 230,000 users of injectables, 76,000 users of Centchroman, and
76,000 users of POP by 2021. The largest numbers of users for the new methods are projected to come
from highly populated northern states, such as Assam, Bihar, Odisha, Rajasthan, Uttar Pradesh, and
West Bengal. There will be increases in costs for the procurement of contraceptives and capacity
building, but the increased costs are not particularly large when compared with total expenditures on
family planning by the government. The annual budgets required for procuring the commodities at the
current market cost is around Rs. 120 million per year (12 crores) and this represents less than 10
percent of current family planning expenditure by the Government of India. The funding estimations of
this study will help the government to allocate its budgets for commodity purchase in a timely manner,
while the rigorous modelling methods will help policymakers to justify their budget allocation requests.

1
1. INTRODUCTION
1.1 Background
India is home to a growing population of over 1.2 billion people that is expected to surpass 1.4 billion by
2026.1 Although the national Total Fertility Rate (TFR) declined from 3.2 to 2.3 births per women
between 2000 and 2013, it remains above the target TFR of 2.1, driven by several high-focus, high-
fertility states. Young age at marriage and first childbirth, short spacing between births, high fertility
among young women, and unmet need for family planning all contribute to high overall fertility,
population growth, maternal and infant mortality, and unsustainable use of resources for health.
The Government of India (GOI) has long recognized the impact of family planning on broader health and
welfare goals, and accordingly was the first country to launch the National Family Planning Programme in
1952.1 The approach of this and successor organizations has evolved over the ensuing 65 years, and now
envisages family planning as a mechanism for averting maternal and child deaths, stabilizing the
population, and promoting economic and social progress. These goals align with various national and
international commitments of the Government of India, including the National Health Mission, the
Sustainable Development Goals, and India’s Family Planning 2020 commitments.2
Along with over 60 other countries in attendance, India committed at the 2012 London Summit on
Family Planning to take political, financial, and service delivery steps to sustain and grow family planning
coverage by 2020.2 Specific commitments by 2020 include increasing financing for family planning to over
US$2 billion, sustaining contraceptive coverage for 100 million women currently using them, expanding
access to services to an additional 48 million women, and expanding the choice of available
contraceptives and family planning methods for all people of reproductive age. At present, for too many
Indian women, early marriage and childbirth followed by sterilization remains the only option. Data from
the fourth National Family Health Survey (NFHS-4) show that less than half of women use any form of
modern contraception, and of those who do, two-thirds have been sterilized.3 More than 26 percent of
Indian women are married by the time they are 18 (NFHS-4) and the contraceptive use by married
adolescents is dismally poor at only 7 percent (NFHS-3).3 Methods to delay or space children are not
widely available: only 1.5 percent of women use an intrauterine contraceptive device (IUCD), 4 percent
use oral contraceptive pills (OCPs), and 5 percent use condoms (NFHS-4).3
A key indicator for measuring progress on the Family Planning 2020 commitments is the Modern
Methods Contraceptive Prevalence Rate (mCPR). Methods counted toward the mCPR and covered
under the National Family Planning Programme include birth spacing methods like OCPs, condoms,
IUCDs, and permanent methods of male and female sterilization. New methods being added to expand
choice and access include Depot Medroxyprogesterone Acetate (DMPA) Injectable; Centchroman, a
weekly pill developed in India; Progesterone-only Pills (POPs); and implants.1 Piloting of POP and
approval for new contraceptive implants are still underway.1 Increasing choice and introducing new
contraceptive methods in India could play a significant role in reducing the unmet need of a large
1 Department of Health and Family Welfare. 2016. Annual Report of Department of Health and Family Welfare for the
year of 2015-16. Ministry of Health and Family Welfare. Government of India.
2 Family Planning Division. 2014. India’s ‘Vision FP 2020’. Ministry of Health and Family Welfare. Government of India.
3 International Institute for Population Sciences (India) and Ministry of Health and Family Welfare. 2016. National Family
Health Survey 4 (NFHS-4): India Fact Sheet.

2
proportion of adolescents and young couples. The inclusion of new family planning methods under the
National Family Planning Programme will also impact demand for services, the mCPR, and funding for
procurement, provision, and capacity building.
DMPA Injectable has been approved in India and available through private providers since 1994.4 Users
receive an intramuscular injection every three months (or within 11 to 17 weeks after last injection),
which results in three months of contraceptive protection that is safe, is highly effective, and has been
linked to additional health benefits. Drawbacks of DMPA may include menstrual changes, other side
effects like headache and dizziness, and a delay in return to fertility after use has been discontinued.
DMPA provides no protection from HIV or other sexually transmitted infections (STIs), which providers
must make clear to patients during counselling.
Centchroman has been available under subsidy by the Social Marketing Programme in India since 1995,
and is now being added to the National Family Planning Programme.1, 4 Also known in India by the names
Saheli and Novex, Centchroman (ormeloxifene) is a non-steroidal weekly OCP developed at India’s
Central Drug Research Institute for use as an alternative to daily progesterone-estrogen combination
pills.5 Centchroman functions by preventing implantation of a fertilized ovum, thus preventing pregnancy,
without disrupting the normal ovulatory cycle or causing other side effects like nausea or bleeding. Like
DMPA Injectable, Centchroman offers no protection against HIV or other STIs.4
1.2 Problem Statement and Objectives
Three new contraceptives are being added to India’s public sector family planning program, with
widespread use expected to begin in 2017. The three contraceptives are DMPA Injectable,
Centchroman, and POPs. Of these, DMPA Injectable and Centchroman are ready for roll-out.
Widespread introduction of POP is planned starting in 2018. A fourth contraceptive, implants, is not yet
approved; its roll-out is expected in about two years. There is a need to ensure adequate funding for
procurement and supply of these new contraceptives within the government budgets, as well as
financing to support capacity-building activities. In view of this, the USAID-funded Health Finance and
Governance team applied a modelling tool to project state-wise modern method contraceptive
prevalence rates, new users, and funding requirements for new family planning commodities over the
next five years.
The study has three main objectives:
 Estimate the demand for the new contraceptives for the next five years
 Estimate the cost of procuring the required commodities
 Estimate the funds required to build provider capacity
4 Urban Health Initiative. 2012 [cited 2017 April 17]. What are Progestin-Only Injectables? Presentations for Service
Providers. Urban Health Initiative India. Available from http://www.uhi-
india.org.in/toolkits/dmpa/DMPA_PPT_Service_Providers_Eng.pdf
5 Central Drug Research Institute. 2017 [cited 2017 April 17]. Centchroman. CSIR-Central Drug Research Institute.
Available from http://www.cdri.res.in/Centchroman.aspx

3
2. METHODS
2.1 Projections of mCPR and estimation of additional users
over next five years
The national trend of growth in the mCPR has been estimated using the serial national surveys (NFHS,
District Level Household Survey (DLHS), and Annual Health Survey (AHS)) with the Family Planning
Estimation Tool.6,7 This projection shows little or no growth in mCPR. We applied this same approach
to the state level2 and assumed that no state would have an mCPR above 70 percent, the current level
for Andhra Pradesh, because that level is more than sufficient to achieve replacement-level fertility.
2.2 Impact of introduction of new methods
International experience shows that introduction of new methods eventually increases mCPR by 5–8
percentage points for each new method that becomes available to the entire population.8 We assume
that the gradual roll-out of a completely new method, injectables, coupled with Centchroman and POP,
which are essentially new forms of the OCP, will increase the total market by at least 6–7 percentage
points by 2020–2021, and the mCPR from 47.8 percent, as measured by the NFHS-4, to 57 percent by
2021.
2.3 The number of total and additional users of modern
contraception
The total number of family planning users has been estimated by multiplying the projected mCPR by the
projected number of married women of reproductive age (MWRA). State-level projections were made
using the same methods and adjusted so that the aggregate growth at the state levels matched the
national projection. Additional users are calculated as total users in any future year minus users in the
base year, 2016. Note that ‘additional users’ are different from new users. New users might refer to
those who are new to family planning or to a particular method or source. Since some women will
discontinue contraceptive use and others will age out of the reproductive age group, they need to be
replaced by new users to maintain the current number of total users. So there could be a significant
number of ‘new’ users even if there were no ‘additional’ users. Additional users represent the net
increase in the total number of users.
6 New JR, Cahill N, Stover J, Gupta YP, Alkema L. Forthcoming. Rates and trends in contraceptive prevalence, unmet
need and demand for family planning for 29 states and union territories in India: a subnational analysis with the Family
Planning Estimation Tool. Lancet Global Health.
7Alkema, L, Kantorova, V, Menozzi, C, and Biddlecom, A. 2013. National, regional, and global rates and trends in
contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive
analysis. Lancet 381:1642–1652.
8Ross J, Stover J. 2013. Use of modern contraception increases when more methods become available: analysis of
evidence from 1982-2009. Global Health Science and Practice 1(2):203–212. doi: 10.9745/GHSP-D-13-00010.

4
2.4 Method mix among additional users for new methods
Data from the NFHS-4 indicate the current method mix in each state. To estimate how the method mix
would change with the addition of the new methods, we relied on international experience.
Data on family planning methods from Demographic and Health Surveys for 83 countries show a range
of 0 percent to 32 percent of MWRA age using injectables as their main method of family planning. The
median prevalence of injectable use is 4.0 percent, and the mean is 7.4 percent with an inner-quartile
range of 1.2 percent–11.3 percent.
A global analysis of the oral contraceptive market by Global One-Stop Reports shows that POPs and
combined oral contraceptive pills (COCs) share the market equally. Since POPs may have fewer side
effects, they may be preferred by some women. That may help to grow the market but would also likely
cut into the share of COCs.
Contraceptive use in India is primarily for limiting births and is dominated by female sterilization. The
use of these limiting methods is already at high levels and has brought the TFR down to replacement
level in many states. As a result, we do not expect the new methods to have a large effect on the use of
permanent methods. Instead, we expect that the new methods will be most useful for those wanting to
space their children and those who, for whatever reason, do not adopt sterilization. Currently, these
women use pills, condoms, and traditional methods. Since each of these methods has some problems, a
significant portion of women cycle in and out of use and non-use. The new methods are intended to
provide better options for these women as they are more convenient to use and should have fewer side
effects.
For these reasons, we have assumed that the number of users of the current methods other than OCPs
will remain constant. (Note that there will still be new users of existing methods to replace drop-outs
and those reaching age 50.) Additional users will be divided among injectables and oral contraceptives.
Initially, injectables will account for one-quarter of new methods users, but this share will grow to 50
percent by 2021 as injectables become more widely known. The remaining additional users will be
equally divided among COCs, POPs, and Centchroman, as shown in Table 1. We have assumed faster
roll-out of injectables in the focus districts as initial efforts will prioritize those districts. Note that these
distributions apply to additional users only, so the number of users of each method will be low in the
first year and increase gradually until 2021. State-level projections for the new family planning methods
are shown in Annex A.

5
Table 1: Distribution of additional users by new methods
Focus districts in 7 focus states
Inject. OCP Centchroman POP
1st
year 25% 55% 20%
2nd
year 30% 23% 23% 23%
3rd
year 40% 20% 20% 20%
4th
year 45% 18% 18% 18%
5th
year 50% 17% 17% 17%
Non-focus districts in 7 focus states and all non-focus states
Inject. OCP Centchroman POP
1st year 20% 60% 20%
2nd year 25% 25% 25% 25%
3rd year 30% 23% 23% 23%
4th year 40% 20% 20% 20%
5th year 50% 17% 17% 17%
2.5 Capacity Building
Capacity building of service providers is required at all levels before supplies of new methods start
arriving at the facilities. Three days of training are required for regional trainers to cover injectables,
Centchroman, POPs, COCs, and the emergency contraceptive pill. Similar training is to be held at the
state level and below. Training of trainers at the state level has begun and will be cascaded down to
lower levels in the coming three years. We have made the following assumptions for the training roll-
out:
1. State-level teams will consist of state trainers who have completed postpartum intrauterine
device (PPIUD) or other clinical training.
2. District-level teams will have as trainers obstetricians and gynecologists (OBGYNs) from district
hospitals, sister tutors from a nursing college (if any), and sister tutors of auxiliary nurse midwife
training centers (ANMTCs).
3. District-level teams will train the medical officers (MOs) from community health centers
(CHCs) and primary health centers (PHCs) and sister tutors from ANMTCs will train lady
health visitors (LHVs) and auxiliary nurse midwives (ANMs).
4. LHVs/ANMs will train accredited social health activists (ASHAs) in monthly meetings.

6
The detailed calculation about the number of participants in each state, the number of courses, and the
costs for all states, are given in Annex B. The following norms have been used to calculate the Rs.9
Cost of various courses
*Cost of one training course for district-level officers/CHC/PHC medical officers
(Group A trainees)
 Cost of 2-day training for 15 participants=68,425
 Cost for 10 participants=47,150
 Cost of training for 20 participants=89,700
*Cost one training of 2 days for LHV/ANM (Group C and D trainees)
*All calculations based on state norms
Assumptions about phasing of training
Non-focus states
1. All state- and district-level trainings will be done in 2017-18.
2. All subdivision (SD)-level training will also be done in 2017-18.
3. 50% of CHCs and of PHCs, and all LHVs in non-focus states will be covered in 2017-18.
4. 50% of CHCs and of PHCs will be covered in 2018-19 in non-focus states.
5. All ANMs will be covered in 2019-20 in non-focus states.
Focus states and focus districts
1. All state- and district-level trainings will be done in 2017-18.
2. All SD-level training will also be done in 2017-18.
3. 50% of CHCs and of PHCs, and all LHVs will be covered in 2017-18
4. 50% of CHCs, PHCs, and ANMs will be covered in 2018-19.
5. 50% of ANMs will be covered in 2019-20.
9 US$ 1 equal to Rs. 67.2 in 2016.

7
3. RESULTS
The total number of modern method users increases from 128 million in 2016 to 150 million in 2021,
resulting in 22 million additional users of modern contraception (Figure 1).
Figure 1: Number of modern method users 2016–2021
The projected mCPR by state is given in Table 2. Detailed projections by state and year for MWRA,
mCPR, additional users for all methods, and their break-up method-wise are given in Annex A. We
project that 17 states will have mCPR above 60 percent by 2021. The amount of increase varies by state
according to their historical trends. The largest increases in mCPR are projected for Arunachal Pradesh,
Bihar, Chhattisgarh, Delhi, Gujarat, Himachal Pradesh, Jammu & Kashmir, Kerala, Meghalaya, Manipur,
Sikkim, Tamil Nadu, Uttar Pradesh, and West Bengal.
Table 2: Projected mCPR for calculating the users of modern methods
State
Projected mCPR for all modern methods (%)
2016 2017 2018 2019 2020 2021
Andaman & Nicobar 50 51 52 54 55 56
Andhra Pradesh 70 70 70 70 70 70
Arunachal Pradesh 48 50 51 52 54 55
Assam 43 44 46 47 48 49
Bihar 28 30 31 32 34 35
Chandigarh 68 69 70 70 70 70
115
120
125
130
135
140
145
150
155
2016 2017 2018 2019 2020 2021
Million
Years

8
State
Projected mCPR for all modern methods (%)
2016 2017 2018 2019 2020 2021
Chhattisgarh 58 60 61 62 64 65
Daman & Diu 61 62 63 65 66 67
Delhi 59 61 62 63 64 66
Dadar & Nagar 60 61 62 64 65 66
Goa 27 28 29 31 32 33
Gujarat 60 61 63 64 65 67
Himachal Pradesh 60 61 63 64 65 67
Haryana 60 61 62 64 65 66
Jharkhand 48 49 50 51 53 54
Jammu & Kashmir 50 51 53 54 55 57
Karnataka 55 56 57 59 60 61
Kerala 56 58 59 60 61 63
Meghalaya 22 24 25 26 28 29
Maharashtra 65 66 67 69 70 70
Manipur 16 17 19 20 21 23
Madhya Pradesh 53 54 55 57 58 59
Mizoram 62 63 64 66 67 68
Nagaland 30 31 32 33 35 36
Odisha 51 52 53 54 56 57
Pondicherry 62 63 65 66 67 68
Punjab 62 63 64 66 67 68
Rajasthan 63 64 65 67 68 69
Sikkim 49 51 52 53 54 56
Tamil Nadu 54 56 57 58 60 61
Tripura 45 46 47 48 50 51
Uttarakhand 52 53 54 56 57 58
Uttar Pradesh 39 40 42 43 44 46
West Bengal 59 60 62 63 64 66

9
Table 3 shows the projected number of additional users for all methods for all states of India.
Table 3: Number of additional users of all methods in all states of India 2017–2021
State 2017 2018 2019 2020 2021 2017-2021
Andaman & Nicobar 2,000 2,000 2,000 2,000 2,000 10,000
Andhra Pradesh 95,000 93,000 92,000 91,000 90,000 462,000
Arunachal Pradesh 5,000 5,000 5,000 5,000 5,000 26,000
Assam 118,000 121,000 124,000 127,000 130,000 620,000
Bihar 354,000 356,000 358,000 359,000 359,000 1,787,000
Chandigarh 7,000 6,000 4,000 5,000 5,000 26,000
Chhattisgarh 107,000 106,000 105,000 104,000 103,000 526,000
Daman & Diu 1,000 1,000 1,000 1,000 2,000 7,000
Delhi 106,000 111,000 116,000 121,000 127,000 580,000
Dadar & Nagar 3,000 3,000 3,000 3,000 3,000 14,000
Goa 4,000 4,000 5,000 5,000 5,000 23,000
Gujarat 256,000 255,000 253,000 250,000 246,000 1,259,000
Himachal Pradesh 26,000 26,000 26,000 27,000 27,000 131,000
Haryana 113,000 114,000 114,000 114,000 113,000 568,000
Jharkhand 125,000 128,000 131,000 134,000 137,000 654,000
Jammu & Kashmir 39,000 40,000 41,000 41,000 42,000 203,000
Karnataka 242,000 246,000 250,000 254,000 258,000 1,249,000
Kerala 113,000 113,000 112,000 112,000 111,000 561,000
Meghalaya 8,000 8,000 8,000 8,000 9,000 41,000
Maharashtra 500,000 498,000 494,000 490,000 185,000 2,166,000
Manipur 7,000 8,000 8,000 8,000 8,000 39,000
Madhya Pradesh 305,000 307,000 309,000 310,000 311,000 1,543,000
Mizoram 4,000 4,000 4,000 4,000 4,000 20,000
Nagaland 5,000 5,000 5,000 5,000 5,000 25,000
Odisha 147,000 150,000 152,000 154,000 157,000 760,000
Pondicherry 5,000 5,000 5,000 6,000 6,000 27,000
Punjab 102,000 104,000 105,000 107,000 108,000 526,000
Rajasthan 314,000 313,000 312,000 309,000 306,000 1,555,000
Sikkim 2,000 2,000 2,000 2,000 2,000 12,000
Tamil Nadu 262,000 266,000 270,000 273,000 277,000 1,348,000
Tripura 15,000 15,000 16,000 16,000 16,000 78,000
Uttarakhand 38,000 39,000 40,000 41,000 41,000 199,000
Uttar Pradesh 702,000 716,000 731,000 745,000 759,000 3,652,000
West Bengal 348,000 351,000 354,000 358,000 361,000 1,771,000
INDIA 4,460,000 4,472,000 4,473,000 4,507,000 4,238,000 22,151,000

10
The largest number of additional users is projected to come from Uttar Pradesh followed by West
Bengal, Bihar, Madhya Pradesh, and Rajasthan. Except for West Bengal, these are all focus states.
The aggregated users of new methods and OCPs for India are given in Table 4. The state-wise break-up
is given in Annex A. Under the assumptions described above there will be almost 230,000 users of
injectables in 2021, 76,000 users of Centchroman, and 76,000 users of POPs. Centchroman is currently
sold under social marketing so some awareness already exists; thus, we expect faster uptake of it than
of POPs.1
Table 4: Users of new methods and OCPs 2017–2021
Year Injectable OCP Centchroman POP
2017 89903 253072 85745
2018 145,093 102,081 101,908 101,908
2019 145,862 103,876 103,734 103,734
2020 189,800 92,001 92,001 91,877
2021 229,217 76,406 76,299 76,299
Commodity requirement have been calculated by multiplying the number of users given in Table 4 and
the norm per user given in Table 5. The cost of commodities has been calculated by multiplying the
commodities needed by the unit cost given in Table 5.
Table 5: Commodities required per method per year and costs per method per year
Commodities
Annual
requiremen
Unitcost
Commodity requirements (thousands) and cost (Rs. millions)
2017 2018 2019 2020 2021
Units Cost Units Cost Units Cost Units Cost Units Cost
Injectable 4 vials
Rs. 75
per vial
360 27.0 574 43.1 583 43.5 759 56.6 917 68.3
Centchroman 8 strips
Rs. 2.50
per strip
686 2 811 2.03 824 2.06 731 1.83 606 1.52
POP
13
cycles
Rs. 58
per strip
1,320 76.4 1,340 77.7 1,190 68.8 985 57.1
Total 1046 28.7 2,703 121 2,750 123 2,680 127 2,510 127

11
The cost for three new methods for five years (2017–2021) is summarized in Table 6.
Table 6: Total cost of new methods, 2017–2021 (RS. millions)
Injectable 239
Centchroman 10
POP 280
Total 529
The average annual cost of new contraceptives represents 7 percent of current family planning
expenditure. (Family planning expenditure is calculated from direct expenditure reported under family
planning headings, Rs. 7,265.6 million). Given the government’s strong commitment to family planning, it
seems likely that required funds can be made available from domestic resources.
The aggregated cost of training of service providers is given in Table 7.
Details are provided in in Annex B.
Table 7: Total cost of training (Rs. millions)
2017 2018 2019
State level 1.05
District level 6.41
SD level 4.7
CHC level
Non-focus states 32.9 32.9
Focus states 35.1 35.1
LHV 70.1
ANM
Non-focus states 70.8
Focus states 16.3 16.2
Total 150 84.2 87.0
Total = 321

12
The total cost of procuring new contraceptives and capacity building of service providers is given in
Table 8. The total annual cost represents about 10 percent of current family planning expenditures.
Expenditures are higher in the first three years while training is underway but then drop once the scale-
up phase is complete.
Table 8: Annual and total cost of commodities and capacity building for new methods
2017-2021 (Rs. millions)
2017 2018 2019 2020 2021 2017-2021
Injectable 28 43 44 57 68 239
Centchroman 3 2 2 2 2 11
POP 76 78 69 57 280
Total 31 121 123 127 127 529
Cost of capacity building 150 84 87 321
Total 181 205 211 128 127 852
The cost of educational material to be used for training will be developed from existing resources; this
cost is not included here.

13
4. CONCLUSION
The modelling results show that the method mix scenario will change over the next five years with the
introduction of three new contraceptives. The new contraceptive methods are not expected to have a
large effect on the use of permanent methods; instead, it is assumed that the new methods will have
more uptakes from young, newly married, low parity couples and adolescents, who aspire to delay and
space their children. Currently, these women use pills, condoms, and traditional methods and because of
side effects or inconvenience of these methods, large percentages of the women will switch and
discontinue the methods. The new methods (DMPA, Centchroman, and POP) are intended to provide
better options for these women, as they are more convenient and have fewer side effects.
The largest number of users for the new methods is projected to come from highly populated northern
states, such as Assam, Bihar, Odisha, Rajasthan, Uttar Pradesh, and West Bengal. It is estimated that
there will be almost 230,000 users of injectables, and 76,000 users each of Centchroman and of POP in
2021. The annual budgets required for procuring the commodities at the current market cost is around
Rs. 120 million per year (12 crores), less than 10 percent of current family planning expenditure by GOI.
This study provides funding projections and an innovative modelling tool to inform and guide
government budgets, implementation plans, and projected method mix changes over the next five years.
The costs projected by this study will be a useful tool to help GOI allocate its budgets for commodity
purchase in a timely manner. These projections, derived through rigorous modelling methods, will also
help policymakers use the appropriate rationale to justify their budget allocation requests to the
Ministry of Finance and thus will accelerate the complex approval process. Timely budget approvals and
fund flows will enable procurement and distribution processes to continue uninterrupted and will
prevent stock-outs at health facilities.

15
ANNEX A: STATE-LEVEL PROJECTIONS
FOR MODERN METHODS
CONTRACEPTIVE USE AND COSTS

16
Table A.1: Projections of mCPR during 2007-2021
State
% in
union
mCPR mCPR Annual Projected mCPR -annual increment of 1.3 (Max. mCPR=70)
GR TFR
1998/99 2005/06 Change 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Andaman & Nicobar 1 48 48.05 48.10 48.15 48.20 46.9 47.40 47.90 48.4 50 51 52 54 55 56 1.3 1.5
Andhra Pradesh 1 58.9 67 1.16 68 69.03 69.89 70.76 71.63 72.2 73.07 73.94 75.1 70 70 70 70 70 70 1.3 1.8
Arunachal Pradesh 1 32.8 37.3 0.64 38 48 48 48 48 44.5 45.37 46.23 47.1 48 50 51 52 54 55 1.3 2.4
Assam 1 26.6 27 0.06 28 31 31 31 31 39.5 40.20 40.90 41.6 43 44 46 47 48 49 1.3 2.2
Bihar 1 22.4 28.9 0.93 29 29.91 30.93 31.94 32.95 35.3 36.00 36.50 37.0 38 39 41 42 43 45 1.3 3.4
Chandigarh 1 70 70 70 70 70 66.2 68 69 66.7 68 69 70 70 70 70 1.3 -
Chhattisgarh 1 49.1 7.01 49 49 49 49 55.7 56.13 56.57 57.0 58 60 61 62 64 65 1.3 2.6
Daman & Diu 1 54 54 54 54 54 55.5 57 58 59.4 61 62 63 65 66 67 1.3 -
Delhi 1 56.3 56.5 0.03 58 55 55 55 55 57.1 57.37 57.63 57.9 59 61 62 63 64 66 1.3 2.1
Dadar& Nagar 1 53 53 53 53 53 54.4 56 57 58.3 60 61 62 64 65 66 1.3 -
Goa 1 35.9 37.2 0.19 38 36.75 35.14 33.54 31.93 25.5 25.50 25.50 25.5 27 28 29 31 32 33 1.3 1.7
Gujarat 1 53.3 56.5 0.46 58 56 56 56 56 58.0 58.23 58.47 58.7 60 61 63 64 65 67 1.3 2.4
Himachal Pradesh 1 60.8 71 1.46 70 70 70 70 70 57.7 58.07 58.43 58.8 60 61 63 64 65 67 1.3 1.9
Haryana 1 53.2 58.3 0.73 59 59.33 59.19 59.06 58.93 50.7 53.27 55.83 58.4 60 61 62 64 65 66 1.3 2.1
Jharkhand 1 31.1 4.44 32 32 32 32 32 44.0 44.73 45.47 46.2 48 49 50 51 53 54 1.3 2.8
Jammu & Kashmir 1 41.7 44.9 0.46 46 43 43 43 43 47.4 47.87 48.33 48.8 50 51 53 54 55 57 1.3 2.4
Karnataka 1 56.5 62.5 0.86 64 62.38 61.09 59.81 58.53 60.4 58.07 55.73 53.4 55 56 57 59 60 61 1.3 1.8
Kerala 1 56.1 57.9 0.26 59 56 56 56 56 54.1 54.37 54.63 54.9 56 58 59 60 61 63 1.3 1.9

17
State
% in
union
mCPR mCPR Annual Projected mCPR -annual increment of 1.3 (Max. mCPR=70)
GR TFR
1998/99 2005/06 Change 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Meghalaya 1 15.5 18.5 0.43 20 19.84 20.02 20.20 20.38 15.0 17.03 19.07 21.1 22 24 25 26 28 29 1.3 3.0
Maharashtra 1 59.9 64.9 0.71 66 65.73 65.39 65.06 64.73 64.6 64.20 63.80 63.4 65 66 67 69 70 70 1.3 1.9
Manipur 1 25.9 23.6 -0.33 25 23.50 22.24 20.99 19.73 11.8 12.77 13.73 14.7 16 17 19 20 21 23 1.3 2.6
Madhya Pradesh 1 42.6 52.8 1.46 54 53.64 53.32 53.00 52.68 58.1 55.87 53.63 51.4 53 54 55 57 58 59 1.3 2.3
Mizoram 1 57.1 59.6 0.36 61 57 57 57 57 59.1 59.50 59.90 60.3 62 63 64 66 67 68 1.3 2.9
Nagaland 1 24.2 22.5 -0.24 24 - - - - 24.6 25.80 27.00 28.2 30 31 32 33 35 36 1.3 3.8
Odisha 1 40.3 44.7 0.63 46 40 40 40 40 47.2 47.87 48.53 49.2 51 52 53 54 56 57 1.3 2.4
Pondicherry 1 61 59 59 59 59 59.0 59.53 60.07 60.6 62 63 65 66 67 68 1.3 1.7
Punjab 1 53.8 56.1 0.33 57 63 63 63 63 59.7 59.90 60.10 60.3 62 63 64 66 67 68 1.3 2.0
Rajasthan 1 38.1 44.4 0.90 46 55 55 55 55 61.2 61.27 61.33 61.4 63 64 65 67 68 69 1.3 3.8
Sikkim 1 41.4 48.7 1.04 50 49.61 49.37 49.12 48.88 54.9 52.57 50.23 47.9 49 51 52 53 54 56 1.3 1.2
Tamil Nadu 1 50.3 60 1.39 61 60.15 59.14 58.14 57.13 53.0 53.03 53.07 53.1 54 56 57 58 60 61 1.3 1.7
Tripura 1 44.9 5 9.78 14.55 19.33 24.10 40.6 41.47 42.33 43.2 45 46 47 48 50 51 1.3 1.7
Uttarakhand 1 55.5 34 34 34 34 34 54.3 53.00 51.70 50.4 52 53 54 56 57 58 1.3 2.1
Uttar Pradesh 1 22 29.3 1.04 30 27 27 27 27 37.8 37.77 37.73 37.7 39 40 42 43 44 46 1.3 3.8
West Bengal 1 47.3 49.9 0.37 51 51.90 52.74 53.59 54.43 59.5 58.93 58.37 57.8 59 60 62 63 64 66 1.3 1.8
INDIA 257,400,487 52.2

18
Table A.2: Projected total and additional users for all methods during 2017-2021
State
Users of all modern methods
2016 2017 2018 2019 2020 2021
Andaman & Nicobar 41527 43383 45314 47328 49428 51620
Andhra Pradesh 12564054 12658664 12752136 12844489 12935743 13025918
Assam 2564163 2681745 2802438 2926306 3053416 3183832
Bihar 7564922 7918959 8275331 8633399 8992490 9351901
Chandigarh 149291 155976 161655 166001 170600 175463
Chhattisgarh 3011266 3118299 3224718 3330209 3434442 3537075
Daman & Diu 26323 27636 28995 30400 31852 33352
Delhi 2148469 2254188 2364806 2480564 2601710 2728497
Dadar & Nagar 44167 46673 49278 51986 54798 57717
Goa 74689 79091 83577 88149 92810 97559
Gujarat 7651422 7907520 8162181 8414726 8664448 8910612
Haryana 3119322 3232472 3346022 3459769 3573499 3686991
Jharkhand 2971386 3096182 3223970 3354801 3488728 3625804
Jammu & Kashmir 1011907 1051248 1091239 1131881 1173170 1215108
Karnataka 6839071 7080830 7326591 7576373 7830202 8088097
Kerala 3965323 4077936 4190466 4302778 4414731 4526178

19
State
Users of all modern methods
2016 2017 2018 2019 2020 2021
Meghalaya 104183 111928 119885 128055 136444 145055
Maharashtra 15224109 15723784 16221328 16715516 17205067 17390531
Manipur 73504 80832 88386 96171 104191 112452
Madhya Pradesh 7800247 8105061 8412180 8721154 9031509 9342752
Mizoram 106899 110792 114767 118824 122965 127189
Nagaland 88112 92842 97684 102646 107738 112970
Odisha 4069648 4216783 4366313 4518258 4672636 4829469
Pondicherry 156334 161653 167053 172534 178095 183738
Punjab 3273702 3376065 3479879 3585148 3691878 3800073
Rajasthan 9002363 9316605 9629969 9941695 10250989 10557028
Sikkim 54978 57197 59460 61766 64116 66511
Tamil Nadu 8042333 8304312 8570067 8839633 9113046 9390341
Tripura 339768 354676 369898 385439 401298 417480
Uttarakhand 975978 1014114 1053046 1092784 1133336 1174712
Uttar Pradesh 14416291 15118149 15834429 16565010 17309756 18068510
West Bengal 11230655 11578286 11929284 12283590 12641142 13001880
INDIA 128191971 132652442 137124495 141597685 146104554 150342732

20
Table A.2: Projected total and additional users for all methods during 2017-2021 (Cont.)
State
Additional users of all methods
2017 2018 2019 2020 2021
Andaman & Nicobar 1855 1932 2013 2100 2192
Andhra Pradesh 94611 93472 92353 91254 90175
Arunachal Pradesh 4962 5069 5177 5286 5395
Assam 117582 120693 123868 127110 130417
Bihar 354036 356372 358068 359091 359411
Chandigarh 6685 5679 4346 4599 4863
Chhattisgarh 107033 106420 105491 104233 102633
Daman & Diu 1314 1359 1405 1452 1500
Delhi 105718 110618 115758 121145 126787
Dadar & Nagar 2506 2606 2708 2812 2919
Goa 4402 4486 4572 4660 4750
Gujarat 256098 254661 252545 249722 246163
Himachal Pradesh 25584 25916 26248 26579 26910
Haryana 113150 113550 113747 113730 113492
Jharkhand 124797 127788 130831 133926 137076
Jammu & Kashmir 39341 39991 40641 41290 41938
Karnataka 241759 245760 249783 253828 257895
Kerala 112613 112530 112312 111953 111446

21
State
Additional users of all methods
2017 2018 2019 2020 2021
Meghalaya 7746 7956 8171 8389 8611
Maharashtra 499675 497545 494187 489551 185464
Manipur 7328 7554 7785 8020 8261
Madhya Pradesh 304814 307119 308974 310355 311243
Mizoram 3893 3975 4057 4141 4224
Nagaland 4730 4842 4962 5092 5232
Odisha 147135 149530 151945 154378 156832
Pondicherry 5319 5400 5481 5561 5643
Punjab 102363 103814 105270 106730 108195
Rajasthan 314242 313364 311726 309294 306039
Sikkim 2220 2262 2307 2350 2394
Tamil Nadu 261979 265754 269566 273412 277295
Tripura 14908 15222 15540 15859 16182
Uttarakhand 38136 38932 39738 40552 41376
Uttar Pradesh 701858 716280 730582 744745 758754
West Bengal 347630 350998 354306 357552 360738
INDIA 4460471 4472054 4473190 4506869 4238178

22
Table A.3: mCPR and Method mix
State
Prevalence of mCPR by methods and method mix (based on NFHS4 and DLHS4/ AHS3 for remaining states/UTS)
mCPR prevalence by methods Method mix (%)
Modern
Sterilization
Femalester.
Malester.
Iucd/Ppiucd
Pill
Condom
Sterilization
Ppiucd/Iucd
Pill
Condom
Andaman & Nicobar 48.4 39.9 39.9 0 2.1 2.2 4.2 82.4 4.3 4.5 8.7
Andhra Pradesh 69.5 68.9 68.3 0.6 0.2 0.2 0.2 99.1 0.3 0.3 0.3
Arunachal Pradesh 43.3 21.6 21.5 0.1 3.8 14.3 3.6 49.9 8.8 33.0 8.3
Chandigarh 58.2 21.9 20.6 1.3 5.4 3.6 27.3 37.6 9.3 6.2 46.9
Daman & Diu 31.6 25.7 25.7 0 2.4 1.3 2.2 81.3 7.6 4.1 7.0
Delhi 56.1 22.8 22 0.8 5 4.4 23.9 40.6 8.9 7.8 42.6
Dadar & Nagar 38 31.7 31.7 0 1.4 1.2 3.7 83.4 3.7 3.2 9.7
Goa 24.6 16.3 16.3 0 0.9 0.3 7.1 66.3 3.7 1.2 28.9
Gujarat 43 33.7 33.6 0.1 3 1.4 4.9 78.4 7.0 3.3 11.4
Himachal Pradesh 57.6 45.7 41.8 3.9 0.8 1.2 9.9 79.3 1.4 2.1 17.2
Haryana 59.1 38.7 38.1 0.6 5.7 2.7 12 65.5 9.6 4.6 20.3
Jammu & Kashmir 55.1 36.8 32.8 4 2.8 3.7 11.8 66.8 5.1 6.7 21.4
Karnataka 50.1 48.6 48.6 0 0.6 0.3 0.6 97.0 1.2 0.6 1.2
Kerala 55.3 40.4 39.7 0.7 4.3 1.2 9.4 73.1 7.8 2.2 17.0

23
State
Prevalence of mCPR by methods and method mix (based on NFHS4 and DLHS4/ AHS3 for remaining states/UTS)
mCPR prevalence by methods Method mix (%)
Modern
Sterilization
Femalester.
Malester.
Iucd/Ppiucd
Pill
Condom
Sterilization
Ppiucd/Iucd
Pill
Condom
Meghalaya 21.3 6.2 6.2 0 2.1 11.7 1.3 29.1 9.9 54.9 6.1
Maharashtra 64.8 53.2 51.1 2.1 3 2.4 6.2 82.1 4.6 3.7 9.6
Manipur 12.4 3.2 3.1 0.1 3.7 4.2 1.3 25.8 29.8 33.9 10.5
Mizoram 58.9 36.7 36.7 0 4.8 15.8 1.6 62.3 8.1 26.8 2.7
Nagaland 22.8 6.7 6.6 0.1 6.3 3.7 6.1 29.4 27.6 16.2 26.8
Odisha 45 28.5 28.3 0.2 1.1 12 3.4 63.3 2.4 26.7 7.6
Pondicherry 61.2 57.4 57.4 0 2.6 0.4 0.8 93.8 4.2 0.7 1.3
Punjab 59.8 34.1 33.3 0.8 4.1 2.2 19.4 57.0 6.9 3.7 32.4
Rajasthan 53.2 40.9 40.7 0.2 1.2 2.4 8.7 76.9 2.3 4.5 16.4
Sikkim 44.1 21 17.6 3.4 6.3 11.6 5.2 47.6 14.3 26.3 11.8
Tamil Nadu 52.3 49.4 49.4 0 1.9 0.2 0.8 94.5 3.6 0.4 1.5
Tripura 42.7 13.9 13.9 0 0.6 26.3 1.9 32.6 1.4 61.6 4.4
Uttarakhand 49 28.1 27.4 0.7 1.6 3.2 16.1 57.3 3.3 6.5 32.9
West Bengal 56.5 29.4 29.3 0.1 1.2 20 5.9 52.0 2.1 35.4 10.4

24
Distribution of additional users by methods
It is assumed that increase in mCPR for reaching the goal of additional users will largely come from existing methods such as sterilization,
PPIUCD/IUCD, condoms, OCP, and new methods and focus districts having TFR of more than 3 since government is having special emphasis in
145 districts in these focus states . Therefore, the analysis will focus of distributing additional users of pill into new methods. The existing users
of OCPs will continue using them.
Table A.4: Distribution of additional users by methods -Non-focus states and districts 2017-2021
State
2017 2018 2019Sterilization
IUCD/PPIU
CD
Inj+Centchr
oman+OCP
+POP
Condom
Sterilization
IUCD/PPIU
CD
Inj+Centchr
oman+OCP
+POP
Condom
Sterilization
IUCD/PPIU
CD
Inj+Centchr
oman+OCP
+POP
Condom
Andaman & Nicobar 1529 80 84 161 1592 84 88 168 1660 87 92 175
Andhra Pradesh 54401 158 158 158 53746 156 156 156 53102 154 154 154
Telengana 39393 114 114 114 38919 113 113 113 38454 112 112 112
Arunachal Pradesh 2475 435 1639 413 2529 445 1674 421 2582 454 1710 430
Chandigarh 2515 620 414 3136 2137 527 351 2664 1635 403 269 2038
Daman & Diu 1069 100 54 91 1105 103 56 95 1142 107 58 98
Delhi 42966 9422 8292 45039 44957 9859 8676 47126 47046 10317 9079 49316
Dadar & Nagar 2090 92 79 244 2174 96 82 254 2259 100 86 264
Goa 2917 161 54 1270 2973 164 55 1295 3030 167 56 1320
Gujarat 200709 17867 8338 29183 199583 17767 8291 29019 197925 17619 8222 28778
Himachal Pradesh 20298 355 533 4397 20562 360 540 4454 20825 365 547 4511
Haryana 74093 10913 5169 22975 74355 10951 5188 23056 74484 10970 5197 23096
Jammu & Kashmir 26275 1999 2642 8425 26709 2032 2685 8564 27143 2065 2729 8704
Karnataka 234521 2895 1448 2895 238402 2943 1472 2943 242304 2991 1496 2991
Kerala 82271 8757 2444 19142 82210 8750 2442 19128 82051 8733 2437 19091

25
State
2017 2018 2019
Sterilization
IUCD/PPIU
CD
Inj+Centchr
oman+OCP
+POP
Condom
Sterilization
IUCD/PPIU
CD
Inj+Centchr
oman+OCP
+POP
Condom
Sterilization
IUCD/PPIU
CD
Inj+Centchr
oman+OCP
+POP
Condom
Meghalaya 2255 764 4255 473 2316 784 4370 486 2378 806 4488 499
Maharashtra 410227 23133 18506 47808 408478 23034 18428 47605 405722 22879 18303 47283
Manipur 1891 2186 2482 768 1949 2254 2559 792 2009 2323 2637 816
Mizoram 2425 317 1044 106 2477 324 1066 108 2528 331 1088 110
Nagaland 1390 1307 768 1265 1423 1338 786 1295 1458 1371 805 1328
Odisha 93186 3597 39236 11117 94702 3655 39875 11298 96232 3714 40519 11480
Pondicherry 4989 226 35 70 5065 229 35 71 5141 233 36 72
Punjab 58371 7018 3766 33208 59198 7118 3819 33679 60028 7217 3873 34151
Rajasthan 241589 7088 14176 51389 240914 7068 14137 51246 239654 7031 14063 50978
Sikkim 1057 317 584 262 1077 323 595 267 1098 330 607 272
Tamil Nadu 247453 9517 1002 4007 251019 9655 1016 4065 254619 9793 1031 4123
Tripura 4853 209 9182 663 4955 214 9376 677 5059 218 9572 691
Uttarakhand 21870 1245 2491 12530 22326 1271 2543 12792 22788 1298 2595 13057
West Bengal 180891 7383 123055 36301 182643 7455 124247 36653 184365 7525 125418 36998

26
Table A.4: Distribution of additional users by methods -Non-focus states and districts 2017-2021 (cont.)
State
2020 2021
Sterilization
IUCD/PPIU
CD
Inj+Centchr
oman+OCP
+POP
Condom
Sterilization
IUCD/PPIU
CD
Inj+Centchr
oman+OCP
+POP
Condom
Andaman & Nicobar 1731 91 95 182 1807 95 100 190
Andhra Pradesh 52470 153 153 153 51850 150 150 150
Telengana 37996 110 110 110 37546 109 109 109
Arunachal Pradesh 2637 464 1746 439 2692 474 1782 449
Chandigarh 1731 427 284 2157 1830 451 301 2281
Daman & Diu 1181 110 60 101 1220 114 62 104
Delhi 49236 10797 9502 51611 51528 11300 9944 54014
Dadar & Nagar 2346 104 89 274 2435 108 92 284
Goa 3088 171 57 1345 3147 174 58 1371
Gujarat 195713 17422 8130 28457 192923 17174 8015 28051
Himachal Pradesh 21088 369 554 4568 21351 374 561 4625
Haryana 74473 10969 5196 23092 74317 10946 5185 23044
Jammu & Kashmir 27576 2098 2773 8842 28009 2131 2816 8981
Karnataka 246229 3040 1520 3040 250173 3089 1544 3089
Kerala 81788 8705 2429 19030 81418 8666 2418 18944

27
State
2020 2021
Sterilization
IUCD/PPIU
CD
Inj+Centchr
oman+OCP
+POP
Condom
Sterilization
IUCD/PPIU
CD
Inj+Centchr
oman+OCP
+POP
Condom
Meghalaya 2442 827 4608 512 2506 849 4730 526
Maharashtra 401916 22664 18132 46840 152264 8586 6869 17745
Manipur 2070 2393 2717 841 2132 2465 2798 866
Mizoram 2580 337 1111 112 2632 344 1133 115
Nagaland 1496 1407 826 1362 1538 1446 849 1400
Odisha 97773 3774 41168 11664 99327 3834 41822 11850
Pondicherry 5216 236 36 73 5292 240 37 74
Punjab 60861 7318 3927 34625 61696 7418 3980 35100
Rajasthan 237785 6977 13953 50580 235282 6903 13806 50048
Sikkim 1119 336 618 277 1140 342 630 282
Tamil Nadu 258252 9933 1046 4182 261919 10074 1060 4242
Tripura 5163 223 9768 706 5268 227 9967 720
Uttarakhand 23256 1324 2648 13324 23728 1351 2702 13595
West Bengal 186054 7594 126567 37337 187711 7662 127695 37670

28
Table A.5: Distribution of additional users by methods -Focus states and districts 2017-2021
Focus
districts
2017 2018 2019
Sterilization
PPIUCD/IUCD
Inj+Centchroman+
OCP+POP
Condom
Sterilization
PPIUCD/IUCD
Inj+Centchroman+
OCP+POP
Condom
Sterilization
PPIUCD/IUCD
Inj+Centchroman+
OCP+POP
Condom
UP 272536 16032 52467 192378 278136 16361 53545 196331 283689 16688 54614 200251
Bihar 301862.7 7291 11666 14583 303854 7339 11743 14679 305300 7374 11799 14749
MP 129153 1512 3932 14821 130130 1524 3962 14933 130916 1533 3986 15023
Rajasthan 102492 3007 6014 21801 102206 2999 5997 21741 101671 2983 5966 21627
Jharkhand 36832 867 4550 4550 37715 887 4659 4659 38613 909 4770 4770
Chhattisgarh 6873 234 249 572 6834 233 248 568 6774 231 246 563
Assam 1874 430 4295 527 1924 441 4409 541 1974 452 4525 555
Other districts
UP 86064 5063 16568 60751 87832 5167 16909 61999 89586 5270 17247 63237
Bihar 15657 378 605 756 15812 382 611 764 15940 385 616 770
MP 134320 1573 4089 15414 134320 1573 4089 15414 134320 1573 4089 15414
Rajasthan 139096 4081 8162 29588 138708 4070 8139 29505 137983 4048 8097 29351
Jharkhand 61387 1444 7583 7583 62859 1479 7765 7765 64356 1514 7950 7950
Chhattisgarh 85915 2931 3114 7144 85423 2914 3096 7103 84677 2889 3069 7041
Assam 29051 6658 66576 8171 29820 6834 68337 8387 30605 7014 70136 8608

29
Table A.5: Distribution of additional users by methods -Focus states and districts 2017-2021 (Cont.)
Focus
districts
2020 2021
Sterilization
PPIUCD/IUCD
Inj+Centchroman+
OCP+POP
Condom
Sterilization
PPIUCD/IUCD
Inj+Centchroman+
OCP+POP
Condom
UP 289189 17011 55673 204133 294629 17331 56720 207973
Bihar 306173 7395 11833 14791 306445 7402 11843 14804
MP 131501 1540 4004 15090 131877 1544 4015 15133
Rajasthan 100878 2960 5920 21458 99816 2929 5857 21232
Jharkhand 39527 930 4883 4883 40456 952 4998 4998
Chhattisgarh 6693 228 243 557 6591 225 239 548
Assam 2026 464 4643 570 2079 476 4764 585
Other districts
UP 91323 5372 17581 64463 93041 5473 17912 65676
Bihar 16039 387 620 775 16108 389 623 778
MP 134320 1573 4089 15414 134320 1573 4089 15414
Rajasthan 136906 4017 8034 29122 135465 3975 7949 28815
Jharkhand 65878 1550 8138 8138 67427 1587 8329 8329
Chhattisgarh 83667 2854 3033 6957 82383 2811 2986 6851
Assam 31405 7197 71971 8833 32222 7384 73843 9063

30
Table A.6: Projected number of users of injectable, OCP, Centchroman and POP -Non Focus states and districts 2017-2021
State
2017 2018 2019
Injectable
(20%)
OCP
Centchroman
POP
Injectable
(25%)
OCP
Centchroman
POP
Injectable
(30%)
OCP
Centchroman
POP
Injectable
(30%)
Andaman & Nicobar 17 51 17 22 22 22 22 27 21 21 21 38
Andhra Pradesh 39 163 54 48 48 48 48 57 44 44 44 75
Telengana 16 116 39 20 20 20 20 23 18 18 18 30
Arunachal Pradesh 328 47 16 419 419 419 419 513 399 399 399 698
Chandigarh 83 983 328 88 88 88 88 81 63 63 63 114
Daman & Diu 11 248 83 14 14 14 14 17 13 13 13 24
Delhi 1658 32 11 2169 2169 2169 2169 2724 2118 2118 2118 3801
Dadar & Nagar 16 4975 1658 21 21 21 21 26 20 20 20 36
Goa 11 47 16 14 14 14 14 17 13 13 13 23
Gujarat 1668 32 11 2073 2073 2073 2073 2467 1919 1919 1919 3252
Himachal Pradesh 107 5003 1668 135 135 135 135 164 128 128 128 221
Haryana 1034 320 107 1297 1297 1297 1297 1559 1213 1213 1213 2078
Jammu & Kashmir 528 3102 1034 671 671 671 671 819 637 637 637 1109
Karnataka 290 1585 528 368 368 368 368 449 349 349 349 608
Kerala 489 869 290 610 610 610 610 731 569 569 569 972

31
State
2017 2018 2019
Injectable
(20%)
OCP
Centchroman
POP
Injectable
(25%)
OCP
Centchroman
POP
Injectable
(30%)
OCP
Centchroman
POP
Injectable
(30%)
Meghalaya 851 1466 489 1093 1093 1093 1093 1346 1047 1047 1047 1843
Maharashtra 3701 2553 851 4607 4607 4607 4607 5491 4271 4271 4271 7253
Manipur 496 11104 3701 640 640 640 640 791 615 615 615 1087
Mizoram 209 1489 496 267 267 267 267 326 254 254 254 444
Nagaland 154 627 209 196 196 196 196 242 188 188 188 331
Odisha 7847 461 154 9969 9969 9969 9969 12156 9454 9454 9454 16467
Pondicherry 7 23542 7847 9 9 9 9 11 8 8 8 15
Punjab 753 21 7 955 955 955 955 1162 904 904 904 1571
Rajasthan 2835 2260 753 3534 3534 3534 3534 4219 3281 3281 3281 5581
Sikkim 117 350 117 149 149 149 149 182 142 142 142 247
Tamil Nadu 200 601 200 254 254 254 254 309 241 241 241 418
Tripura 1836 5509 1836 2344 2344 2344 2344 2871 2233 2233 2233 3907
Uttarakhand 498 1494 498 636 636 636 636 779 606 606 606 1059
West Bengal 24611 73833 24611 31062 31062 31062 31062 37625 29264 29264 29264 50627

32
Table A.6: Projected number of users of injectable, OCP, Centchroman and POP -Non Focus states and districts 2017-2021 (Cont.)
State
2020 2021
Injectable
(30%)
OCP
Centchroman
POP
Injectable
(30%)
OCP
Centchroman
POP
Andaman & Nicobar 38 19 19 19 50 17 17 17
Andhra Pradesh 75 37 37 37 92 31 31 31
Telengana 30 15 15 15 38 13 13 12
Chandigarh 114 57 57 57 150 50 50 50
Daman & Diu 24 12 12 12 31 10 10 10
Delhi 3801 1900 1900 1900 4972 1657 1657 1657
Dadar & Nagar 36 18 18 18 46 15 15 15
Goa 23 11 11 11 29 10 10 10
Gujarat 3252 1626 1626 1626 4007 1336 1336 1336
Haryana 2078 1039 1039 1039 2592 864 864 864
Jammu & Kashmir 1109 555 555 555 1408 469 469 469
Karnataka 608 304 304 304 772 257 257 257
Kerala 972 486 486 486 1209 403 403 403

33
State
2020 2021
Injectable
(30%)
OCP
Centchroman
POP
Injectable
(30%)
OCP
Centchroman
POP
Meghalaya 1843 922 922 922 2365 788 788 788
Maharashtra 7253 3626 3626 3626 3435 1145 1145 1145
Manipur 1087 543 543 543 1399 466 466 466
Mizoram 444 222 222 222 567 189 189 189
Nagaland 331 165 165 165 425 142 142 142
Odisha 16467 8234 8234 8234 20911 6970 6970 6970
Pondicherry 15 7 7 7 18 6 6 6
Punjab 1571 785 785 785 1990 663 663 663
Rajasthan 5581 2791 2791 2791 6903 2301 2301 2301
Sikkim 247 124 124 124 315 105 105 105
Tamil Nadu 418 209 209 209 530 177 177 177
Tripura 3907 1954 1954 1954 4983 1661 1661 1661
Uttarakhand 1059 530 530 530 1351 450 450 450
West Bengal 50627 25313 25313 25313 63847 21282 21282 21282

34
Table A.7: Projected number of users of injectable, OCP, Centchroman and POP -Focus and Non-Focus states and districts 2017-2021
States
2017 2018 2019
Injectable
(25%)
OCP
Centchroman
POP
Injectable
(30%)
OCP
Centchroman
POP
Injectable
(40%)
OCP
Centchroman
POP
Focus districts
UP 13117 28857 10493 16063 12494 12494 12494 21845.59 10923 10923 10923
Bihar 2917 6416 2333 3523 2740 2567 2567 4720 2360 2218 2218
MP 983 2163 786 1189 924 924 924 1594 797 797 797
Rajasthan 1504 3308 1203 1799 1399 1399 1399 2386 1193 1193 1193
Jharkhand 1137 2502 910 1398 1087 1087 1087 1908 954 954 954
Chhattisgarh 62 137 50 74 58 58 58 98 49 49 49
Assam 1074 2362 859 1323 1029 1029 1029 1810 905 905 905
Non-focus districts
UP 3314 10340 3447 8454 2818 2818 2818 5174 4024 4024 4024
Bihar 121 389 130 306 102 102 102 185 144 144 144
MP 818 2454 818 2060 687 687 687 1244 967 967 967
Rajasthan 1632 4897 1632 4070 1357 1357 1357 2429 1889 1889 1889
Jharkhand 1517 4550 1517 3882 1294 1294 1294 2385 1855 1855 1855
Chhattisgarh 623 1869 623 1548 516 516 516 921 716 716 716
Assam 13315 39946 13315 34169 11390 11390 11390 21041 16365 16365 16365

35
Table A.7: Projected number of users of injectable, OCP, Centchroman and POP -Focus and Non-Focus states and districts 2017-2021 (Cont.)
States
2020 2021
Injectable
(25%)
Injectable
(45%)
OCP
Centchroman
POP
Injectable
(50%)
OCP
Centchroman
POP
Focus districts
UP 13117 25052.74 10207 10207 10207 28360 9453 9453 9453
Bihar 2917 5324.741 2169 2169 2046 5922 1974 1868 1868
MP 983 1801.597 734 734 734 2007 669 669 669
Rajasthan 1504 2663.778 1085 1085 1085 2929 976 976 976
Jharkhand 1137 2197.231 895 895 895 2499 833 833 833
Chhattisgarh 62 109.1779 44 44 44 119 40 40 40
Assam 1074 2089.475 851 851 851 2382 794 794 794
Non-focus districts
UP 3314 7032 3626 3626 3626 8956 2985 2985 2985
Bihar 121 248 125 125 125 311 104 104 104
MP 818 1665 837 837 837 2088 696 696 696
Rajasthan 1632 3213 1579 1579 1579 3975 1325 1325 1325
Jharkhand 1517 3255 1691 1691 1691 4165 1388 1388 1388
Chhattisgarh 623 1213 591 591 591 1493 498 498 498
Assam 13315 28788 15018 15018 15018 36922 12307 12307 12307

36
Table A.8: Total users of new methods -all states and districts 2017-2021
States
2017 2018 2019 2020 2021
Injectable
OCP
Centchroma
n
POP
Injectable
OCP
Centchroma
n
POP
Injectable
OCP
Centchroma
n
POP
Injectable
OCP
Centchroma
n
POP
Injectable
OCP
Centchroma
n
POP
UP 16563 39197 13940 24518 15312 15312 15312 27020 14947 14947 14947 32085 13833 13833 13833 37316 12439 12439 12439
Bihar 3046 6805 2463 3829 2842 2668 2668 4904 2504 2362 2362 5573 2294 2294 2170 6233 2078 1971 1971
MP 1801 4616 1604 3249 1611 1611 1611 2838 1764 1764 1764 3467 1571 1571 1571 4095 1365 1365 1365
Rajasthan 3136 8205 2835 5869 2756 2756 2756 4815 3082 3082 3082 5877 2664 2664 2664 6903 2301 2301 2301
Jharkhand 2654 7052 2427 5280 2381 2381 2381 4293 2809 2809 2809 5452 2587 2587 2587 6663 2221 2221 2221
Chhattisgarh 685 2006 673 1622 574 574 574 1019 765 765 765 1322 636 636 636 1613 538 538 538
Assam 14389 42308 14174 35491 12418 12418 12418 22851 17270 17270 17270 30878 15870 15870 15870 39304 13101 13101 13101
Andaman &
Nicobar
17 51 17 22 22 22 22 27 21 21 21 38 19 19 19 50 17 17 17
Andhra
Pradesh
54 163 54 48 48 48 48 57 44 44 44 75 37 37 37 92 31 31 31
Telengana 39 116 39 20 20 20 20 23 18 18 18 30 15 15 15 38 13 13 12
Arunachal
Pradesh
16 47 16 419 419 419 419 513 399 399 399 698 349 349 349 891 297 297 297
Chandigarh 328 983 328 88 88 88 88 81 63 63 63 114 57 57 57 150 50 50 50
Daman & Diu 83 248 83 14 14 14 14 17 13 13 13 24 12 12 12 31 10 10 10
Delhi 11 32 11 2169 2169 2169 2169 2724 2118 2118 2118 3801 1900 1900 1900 4972 1657 1657 1657
Dadar &
Nagar
1658 4975 1658 21 21 21 21 26 20 20 20 36 18 18 18 46 15 15 15
Goa 16 47 16 14 14 14 14 17 13 13 13 23 11 11 11 29 10 10 10
Gujarat 11 32 11 2073 2073 2073 2073 2467 1919 1919 1919 3252 1626 1626 1626 4007 1336 1336 1336
Himachal
Pradesh
1668 5003 1668 135 135 135 135 164 128 128 128 221 111 111 111 280 93 93 93
Haryana 107 320 107 1297 1297 1297 1297 1559 1213 1213 1213 2078 1039 1039 1039 2592 864 864 864
Jammu &
Kashmir
1034 3102 1034 671 671 671 671 819 637 637 637 1109 555 555 555 1408 469 469 469
Karnataka 528 1585 528 368 368 368 368 449 349 349 349 608 304 304 304 772 257 257 257

37
States
2017 2018 2019 2020 2021Injectable
OCP
Centchroma
n
POP
Injectable
OCP
Centchroma
n
POP
Injectable
OCP
Centchroma
n
POP
Injectable
OCP
Centchroma
n
POP
Injectable
OCP
Centchroma
n
POP
Kerala 290 869 290 610 610 610 610 731 569 569 569 972 486 486 486 1209 403 403 403
Meghalaya 489 1466 489 1093 1093 1093 1093 1346 1047 1047 1047 1843 922 922 922 2365 788 788 788
Maharashtra 851 2553 851 4607 4607 4607 4607 5491 4271 4271 4271 7253 3626 3626 3626 3435 1145 1145 1145
Manipur 3701 11104 3701 640 640 640 640 791 615 615 615 1087 543 543 543 1399 466 466 466
Mizoram 496 1489 496 267 267 267 267 326 254 254 254 444 222 222 222 567 189 189 189
Nagaland 209 627 209 196 196 196 196 242 188 188 188 331 165 165 165 425 142 142 142
Odisha 154 461 154 9969 9969 9969 9969 12156 9454 9454 9454 16467 8234 8234 8234 20911 6970 6970 6970
Pondicherry 7847 23542 7847 9 9 9 9 11 8 8 8 15 7 7 7 18 6 6 6
Punjab 7 21 7 955 955 955 955 1162 904 904 904 1571 785 785 785 1990 663 663 663
Rajasthan 753 2260 753 3534 3534 3534 3534 4219 3281 3281 3281 5581 2791 2791 2791 6903 2301 2301 2301
Sikkim 117 350 117 149 149 149 149 182 142 142 142 247 124 124 124 315 105 105 105
Tamil Nadu 200 601 200 254 254 254 254 309 241 241 241 418 209 209 209 530 177 177 177
Tripura 1836 5509 1836 2344 2344 2344 2344 2871 2233 2233 2233 3907 1954 1954 1954 4983 1661 1661 1661
Uttarakhand 498 1494 498 636 636 636 636 779 606 606 606 1059 530 530 530 1351 450 450 450
West Bengal 24611 73833 24611 31062 31062 31062 31062 37625 29264 29264 29264 50627 25313 25313 25313 63847 21282 21282 21282
Total (India) 89903 253072 85745 143538 101574 101401 101401 144923 103173 103031 103031 188583 91418 91418 91294 227734 75911 75805 75805

38
Table A.9: Total requirement of commodities -all states 2017-2021
States
2017 2018 2019
Injectable
OCP
Centchroman
POP
Injectable
OCP
Centchroman
POP
Injectable
OCP
Centchroman
POP
UP 65721 341931 210419 98072 199055 122496 199055 108078 194311 119576 194311
Bihar 12150 60019 36935 15314 36945 21348 34690 19618 32546 18892 30700
MP 7204 40434 24882 12995 20945 12889 20945 11351 22937 14115 22937
Rajasthan 12544 71762 44161 23476 35827 22048 35827 19262 40072 24660 40072
Jharkhand 10616 61613 37916 21120 30956 19050 30956 17172 36516 22471 36516
Chhattisgarh 2740 17408 10713 6490 7460 4591 7460 4076 9949 6122 9949
Assam 57556 367136 225930 141965 161438 99346 161438 91402 224509 138159 224509
Andaman & Nicobar 67 292 180 88 285 176 285 110 278 171 278
Andhra Pradesh 154 1004 619 191 621 382 621 226 572 352 572
Telengana 63 410 253 78 254 156 254 92 234 144 234
Arunachal Pradesh 1311 8521 5244 1674 5441 3348 5441 2052 5186 3191 5186
Chandigarh 331 2150 1323 0 351 1142 703 1142 323 815 502 815
Daman & Diu 43 281 173 0 56 182 112 182 69 175 108 175
Delhi 6633 43117 26533 0 8676 28197 17352 28197 10895 27540 16948 27540
Dadar & Nagar 63 411 253 0 82 267 165 267 103 259 160 259
Goa 43 279 172 0 55 178 109 178 67 169 104 169
Gujarat 6670 43358 26682 0 8291 26947 16583 26947 9867 24941 15348 24941
Himachal Pradesh 426 2772 1706 540 1755 1080 1755 656 1659 1021 1659
Haryana 4135 26880 16542 5188 16860 10375 16860 6236 15763 9700 15763
Jammu & Kashmir 2113 13737 8454 2685 8728 5371 8728 3275 8278 5094 8278
Karnataka 1158 7528 4633 1472 4783 2943 4783 1795 4537 2792 4537
Kerala 1955 12707 7820 2442 7936 4884 7936 2925 7393 4549 7393

39
States
2017 2018 2019
Injectable
OCP
Centchroman
POP
Injectable
OCP
Centchroman
POP
Injectable
OCP
Centchroman
POP
Meghalaya 3404 22125 13615 4370 14204 8741 14204 5386 13614 8378 13614
Maharashtra 14805 96234 59221 18428 59890 36855 59890 21964 55520 34166 55520
Manipur 1986 12906 7942 2559 8315 5117 8315 3164 7998 4922 7998
Mizoram 835 5430 3341 1066 3466 2133 3466 1306 3301 2032 3301
Nagaland 614 3991 2456 786 2553 1571 2553 966 2443 1503 2443
Odisha 31389 204027 125555 39875 129593 79749 129593 48622 122906 75635 122906
Pondicherry 28 181 111 35 115 71 115 43 109 67 109
Punjab 3013 19582 12051 3819 12413 7638 12413 4647 11747 7229 11747
Rajasthan 11341 73717 45364 14137 45944 28273 45944 16875 42657 26251 42657
Sikkim 467 3036 1868 595 1934 1190 1934 728 1841 1133 1841
Tamil Nadu 801 5210 3206 1016 3303 2033 3303 1237 3127 1924 3127
Tripura 7346 47749 29384 9376 30471 18752 30471 11486 29034 17867 29034
Uttarakhand 1992 12951 7970 2543 8263 5085 8263 3114 7872 4844 7872
West Bengal 98444 639886 393776 124247 403804 248495 403804 150502 380435 234114 380435
INDIA 370166 2270776 1397402 574152 1320467 811207 1318212 579690 1341243 824244 1339397

40
Table A.9: Total requirement of commodities -all states 2017-2021(Cont.)
States
2020 2021
Injectable
OCP
Centchroman
POP
Injectable
OCP
Centchroman
POP
UP 128340 179830 110665 179830 149263 161702 99509 161702
Bihar 22291 29825 18354 28216 24932 27009 15771 25627
MP 13868 20419 12566 20419 16381 17746 10921 17746
Rajasthan 23509 34629 21310 34629 27613 29914 18408 29914
Jharkhand 21810 33625 20692 33625 26654 28875 17769 28875
Chhattisgarh 5289 8262 5084 8262 6450 6988 4300 6988
Assam 123511 206304 126956 206304 157214 170316 104810 170316
Andaman & Nicobar 153 248 153 248 199 216 133 216
Andhra Pradesh 298 485 298 485 368 399 246 397
Telengana 122 198 122 198 151 163 100 162
Chandigarh 455 740 455 740 602 652 401 652
Daman & Diu 96 155 96 155 123 134 82 134
Delhi 15203 24704 15203 24704 19888 21545 13259 21545
Dadar & Nagar 142 231 142 231 184 200 123 200
Goa 91 148 91 148 116 126 77 126
Gujarat 13009 21139 13009 21139 16029 17365 10686 17365
Haryana 8313 13509 8313 13509 10370 11234 6913 11234
Jammu & Kashmir 4436 7209 4436 7209 5632 6102 3755 6102
Karnataka 2432 3952 2432 3952 3089 3346 2059 3346
Kerala 3887 6316 3887 6316 4837 5240 3224 5240
Meghalaya 7373 11981 7373 11981 9460 10248 6306 10248

41
States
2020 2021
Injectable
OCP
Centchroman
POP
Injectable
OCP
Centchroman
POP
Maharashtra 29010 47142 29010 47142 13738 14883 9159 14883
Manipur 4346 7063 4346 7063 5596 6062 3731 6062
Mizoram 1777 2888 1777 2888 2266 2455 1511 2455
Nagaland 1322 2148 1322 2148 1698 1840 1132 1840
Odisha 65868 107036 65868 107036 83644 90614 55763 90614
Pondicherry 58 95 58 95 74 80 49 80
Punjab 6282 10209 6282 10209 7961 8624 5307 8624
Rajasthan 22325 36278 22325 36278 27613 29914 18408 29914
Sikkim 989 1607 989 1607 1260 1365 840 1365
Tamil Nadu 1673 2718 1673 2718 2121 2298 1414 2298
Tripura 15629 25397 15629 25397 19933 21595 13289 21595
Uttarakhand 4237 6886 4237 6886 5404 5855 3603 5855
West Bengal 202507 329074 202507 329074 255390 276672 170260 276672
India 754332 1188429 731341 1186820 910937 986849 606441 985463

42
Table A.10: Budget requirement of new contraceptives -all states 2017-2021(Rs.)
States
2017 2018 2019
Injectable
OCP
Centchroman
POP
Injectable
OCP
Centchroman
POP
Injectable
OCP
Centchroman
POP
UP 4929112 526048 7355374 306239 11545213 8105862 298940 11270023
Bihar 911270 92337 1148550 53369 2012027 1471328 47230 1780584
MP 540267 62205 974604 32223 1214796 851353 35287 1330322
Rajasthan 940794 110404 1760667 55119 2077987 1444635 61649 2324172
Jharkhand 796228 94789 1584035 47625 1795447 1287871 56179 2117938
Chhattisgarh 205537 26782 486745 11477 432687 305705 15306 577024
Assam 4316718 564824 10647397 248366 9363390 6855181 345399 13021525
Andaman &
Nicobar
5060 450 6585 439 16551 8237 427 16101
Andhra Pradesh 11587 1548 14323 955 35999 16982 881 33197
Telengana 4733 632 5850 390 14704 6936 360 13559
Arunachal
Pradesh
98324 13110 125561 8371 315577 153873 7979 300793
Chandigarh 24810 3308 26345 1756 66215 24192 1254 47291
Daman & Diu 3243 432 4192 279 10535 5201 270 10167
Delhi 497498 66333 650696 43380 1635417 817118 42369 1597315
Dadar & Nagar 4748 633 6171 411 15511 7696 399 15045
Goa 3221 429 4103 274 10313 5018 260 9810
Gujarat 500284 66705 621846 41456 1562906 740016 38371 1446595
Haryana 310158 41354 389066 25938 977854 467689 24251 914246
Jammu & Kashmir 158506 21134 201407 13427 506204 245617 12736 480135
Karnataka 86860 11581 110371 7358 277400 134614 6980 263145

43
States
2017 2018 2019
Injectable
OCP
Centchroman
POP
Injectable
OCP
Centchroman
POP
Injectable
OCP
Centchroman
POP
Kerala 146621 19549 183142 12209 460296 219344 11373 428777
Meghalaya 255285 34038 327777 21852 823812 403934 20945 789616
Maharashtra 1110388 148052 1382068 92138 3473598 1647291 85415 3220149
Manipur 148917 19856 191893 12793 482292 237318 12305 463913
Mizoram 62653 8354 79974 5332 201001 97948 5079 191471
Nagaland 46054 6141 58927 3928 148102 72477 3758 141679
Odisha 2354162 313888 2990601 199373 7516376 3646672 189087 7128568
Pondicherry 2086 278 2647 176 6653 3224 167 6303
Punjab 225951 30127 286443 19096 719926 348551 18073 681353
Rajasthan 850581 113411 1060256 70684 2664776 1265653 65626 2474118
Sikkim 35033 4671 44632 2975 112174 54610 2832 106752
Tamil Nadu 60110 8015 76220 5081 191567 92776 4811 181360
Tripura 550947 73460 703186 46879 1767340 861449 44668 1683973
Uttarakhand 149431 19924 190688 12713 479263 233560 12111 456567
West Bengal 7383296 984439 9318544 621236 23420607 11287624 585284 22065215
Total cost (India)
in INR
27762452 3493506 43061382 2028018 76456289 43476772 2060610 77685006

44
Table A.10: Budget requirement of new contraceptives -all states 2017-2021 (Rs.) (Cont.)
States
2020 2021
Injectable
OCP
Centchroman
POP
Injectable
OCP
Centchroman
POP
UP 9625526 276662 10430144 11194737 248772 9378702
Bihar 1671807 45884 1636517 1869871 39426 1486379
MP 1040122 31414 1184301 1228590 27302 1029285
Rajasthan 1763168 53276 2008491 2070940 46021 1734987
Jharkhand 1635716 51731 1950246 1999020 44423 1674735
Chhattisgarh 396680 12710 479173 483760 10750 405283
Assam 9263338 317391 11965643 11791087 262024 9878311
Andaman & Nicobar 11454 382 14393 14946 332 12522
Andhra Pradesh 22374 746 28116 27636 614 23020
Telengana 9139 305 11484 11288 251 9402
Chandigarh 34137 1138 42899 45120 1003 37800
Daman & Diu 7167 239 9007 9259 206 7757
Delhi 1140191 38006 1432840 1491611 33147 1249638
Dadar & Nagar 10657 355 13392 13826 307 11583
Goa 6820 227 8571 8689 193 7279
Gujarat 975660 32522 1226079 1202193 26715 1007171
Haryana 623496 20783 783527 777737 17283 651571
Jammu & Kashmir 332715 11091 418112 422423 9387 353897
Karnataka 182392 6080 229205 231642 5148 194065
Kerala 291523 9717 366347 362755 8061 303908

45
States
2020 2021
Injectable
OCP
Centchroman
POP
Injectable
OCP
Centchroman
POP
Meghalaya 552963 18432 694891 709474 15766 594381
Maharashtra 2175784 72526 2734235 1030356 22897 863209
Manipur 325986 10866 409656 419705 9327 351619
Mizoram 133285 4443 167495 169974 3777 142400
Nagaland 99161 3305 124613 127363 2830 106702
Odisha 4940109 164670 6208071 6273296 139407 5255628
Pondicherry 4362 145 5481 5532 123 4635
Punjab 471182 15706 592119 597062 13268 500206
Rajasthan 1674375 55813 2104131 2070940 46021 1734987
Sikkim 74175 2472 93213 94474 2099 79148
Tamil Nadu 125467 4182 157670 159060 3535 133257
Tripura 1172188 39073 1473050 1495007 33222 1252484
Uttarakhand 317798 10593 399366 405320 9007 339568
West Bengal 15188051 506268 19086317 19154224 425649 16046984
Total cost(India)
in INR
56574902 1828352 68835552 68320294 1516103 57156879

46
Table A.11: Summary cost of new methods for 2017-2021(Rs.)
Total cost for injectable during 2017-2021 239,195,801
Total cost for Centchroman during 2017-2021 10,926,589
Total cost for POP during 2017-2021 280,133,726

47
ANNEX B. CAPACITY BUILDING OF STAFF
FOR INTRODUCING NEW CONTRACEPTIVES
Table B.1: Health Infrastructure in all states of India
States/UTs
No. of
districts
No. of
DHs
NO. of
SDH
No. of
CHCs
No. of
PHCs
No. Of
LHV
No. of
SCs
No. of
ANM
No. of
ASHA
Andaman & Nicobar 3 3 0 4 22 20 122 122 407
Andhra Pradesh 13 8 31 179 1069 3038 7659 7659 42681
Arunachal Pradesh 20 14 0 52 117 6 286 286 3826
Chandigarh 1 1 0 2 0 3 16 16 50
Daman & Diu 2 2 0 2 3 0 26 26 80
Delhi 11 41 7 0 5 8 27 27 788
Dadar & Nagar 1 1 0 1 7 0 56 56 338
Goa 2 2 1 4 21 9 209 209 0
Gujarat 33 21 31 320 1247 1007 8063 8063 36029
Himachal Pradesh 12 12 48 78 500 127 2065 2065 24441
Haryana 22 20 20 109 461 286 2569 2569 17404
Jammu & Kashmir 22 23 0 84 637 105 2265 2265 11686
Karnataka 30 32 146 206 2353 1038 9264 9264 41497
Kerala 14 16 79 222 827 13 4575 4575 31829
Meghalaya 11 12 1 27 110 75 428 428 6354
Maharashtra 36 23 86 360 1811 1800 10580 10580 58257
Manipur 9 7 1 17 85 59 421 421 3980
Mizoram 8 8 2 9 57 19 370 370 1091
Nagaland 11 11 0 21 128 24 396 396 1887

48
States/UTs
No. of
districts
No. of
DHs
NO. of
SDH
No. of
CHCs
No. of
PHCs
No. Of
LHV
No. of
SCs
No. of
ANM
No. of
ASHA
Odisha 30 32 27 377 1305 802 6688 6688 44583
Lakshdeep 1 2 3 4 14 102
Pondicherry 4 5 0 3 24 12 54 54 0
Punjab 22 22 41 150 427 467 2951 2951 18722
Sikkim 4 4 0 2 24 16 147 147 666
Tamil Nadu 32 31 240 385 1372 991 8706 8706 3905
Telengana 31 7 31 114 668 944 4863 4863 28439
Tripura 8 6 11 20 91 0 1017 1017 7590
Uttarakhand 13 19 17 59 257 155 1848 1848 11086
West Bengal 20 22 37 347 909 121 10357 10357 51322
UP 75 0 0 0 0 0 0 0 146588
Bihar 38 0 0 0 0 0 0 0 85387
MP 51 0 0 0 0 0 0 0 64627
Rajasthan 33 0 0 0 0 0 0 0 52407
Jharkhand 24 0 0 0 0 0 0 0 40964
Chhattisgarh 27 0 0 0 0 0 0 0 66713
Assam 33 0 0 0 0 0 0 0 30730
Assumptions:
 State-level teams will consist of state trainers who had been doing PPIUD or other clinical training.
 District-level team will have as trainers OBGYNs from district hospitals, sister tutors from nursing college (if any), and sister tutors of
ANMTCs.
 District-level team will train the MOs from CHCs and PHCs, and sister tutors of ANMTCs will train the LHVs and ANMs.
 LHV/ANMs will train ASHAs in monthly meetings.

49
Table B.2: State level courses (number of participants and states/UTs included)
Course 1 (2+1+3+1+2=9 include Daman Dieu, Delhi, D & N, Goa and A & N)
Course 2 (4+4+6=10, MANIPUR+Mizoram+ NAGALAND)
Course 3 (6+8+1=15 Haryana, Punjab and chandigarh)
Course 4 (2+11=13, include Pondicherry and Tamil Nadu)
Course 5 (11+5=16 includes AP and Telengana)
Course 6 (2+7+3=12, Sikkim, West Bengal and Tripura)
Course 7 (11-Gujrat)
Course 8 (6-Himachal Pradesh)
Course 9 (8-J & K)
Course 10 (10+5=15, Karnataka and Kerala)
Course 11 (8+4+4 =16 includes Meghalaya, Arunachal Pradesh and Assam)
Course 12 (12-Maharashtra)
Course 13 (10-Odisha)
Course 14 (5-Uttrakhand)
Course 15 (20-UP)
Course 16 (12+8=20 Bihar+ Jharkhand)
Course 17 (17-MP)
Course 18 (11-Rajasthan)
Course 19 (8-Chhattisgarh)

50
Cost per training course used
*Cost of one training course for district level officers/CHC/PHC medical officers (Group A trainees)
 Cost of 2 day training for 15 participants=68425
 Cost for 10 participants=47150
 Cost of training for 20 participants=89700
*Cost one training of 2 days for LHV/ANM (Group C & D trainees)
*All calculations based on state norms
*All costs in Rs.

51
Table B.3: Cost of state level trainers (Rs.)
S.No. State Level Courses Number of participants Cost
1 Course 1 (Daman Dieu, Delhi, D&N, Goa and A&N) 9 47150
2 Course 2 (Manipur, Mizoram, Nagaland) 10 47150
3 Course 3 (Haryana, Punjab, and Chandigarh) 15 68425
4 Course 4 (Pondicherry and Tamil Nadu) 13 68425
5 Course5 (AP and Telengana) 16 68425
6 Course6 (Sikkim, West Bengal, and Tripura) 12 47150
7 Course7 (Gujrat) 11 47150
8 Course8 (Himachal Pradesh and K&K) 14 68425
9 Course9 (Karnataka and Kerala) 15 68425
10 Course10 (Meghalaya, Arunachal Pradesh, and Assam) 16 68425
11 Course11 (Maharashtra) 12 47150
12 Course12 (Odisha) 10 47150
13 Course13 (UP and Uttarakahnd) 25 110975
14 Course14 (Bihar and Jharkhand)) 20 89700
15 Course15 (MP and Chhatisgarh) 25 110975
16 Course16 (Rajasthan) 11 47150
Total 1052250

52
Table B.4: District level and CHC/PHC level courses required and their cost (Rs.)
State
No of district
level courses*
Cost of
district
level
courses
Total cost-
district
level
SD level
courses
Cost of
Sub-
district
level
courses
Total cost-
SD level
No. of
CHC/PHC
courses
Cost of
CHC/PHC
level courses
Total cost
Andaman & Nicobar 1(10) 47150 47150 0 0 1(22) 110795 110975
Andhra Pradesh 1(16) 68425 68425 1(31) 132250 132250 42(30 each) 132250 132292
Arunachal Pradesh 1(28) 132250 132250 0 0 6(30 each) 132250 793500
Chandigarh 1(4) 23000 23000 0 0
Daman & Diu 1(9) 47150 47150 0 0 23000
Delhi 2(20) 89700 179400 1(7) 47150 47150 1(5) 23300 23000
Dadar & Nagar 1(10) 47150 47150 0 0
Goa 1(9) 47150 47150 combined 0 1(30) 132250 132250
Gujarat 2(20) 89700 179400 1(30) 132250 132250 53(30 ) 132250
Himachal Pradesh 1(24) 110975 110975 2(24) 110975 221950 19(30) 132250 2512750
Haryana 2(20) 89700 179400 1(20) 89700 89700 19(30) 132250 2512750
Jammu & Kashmir 2(23) 110975 221950 0 0 0 24(30) 132250 3174000
Karnataka 3(22) 110975 332925 5(30) 132250 661250 85(30) 132250 11241250
Kerala 2(16) 68425 136850 3(26) 110975 332925 35(30) 132250 4628750
Meghalaya 1(25) 89700 89700 combined 0 0 5(30) 132250 661250
Maharashtra 2(23) 89700 179400 3(29) 132250 396750 72(30) 132250 9522000
Manipur 1(15) 68425 68425 combined 0 0 4(25) 110975 443900
Mizoram 1(16+2=18) 89700 89700 combined 0 0 2(30) 132250 264500
Nagaland 1(22) 110975 110975 combined 0 0 5(30) 132250 661250
Odisha 3(21) 89700 269100 1(27) 132250 132250 56(30) 132250 7406000
Lakshdeep 1(11) 47150 47150 combined 0 0 0 0 0
Pondicherry 1(10) 47150 47150 1(27) 132250 132250 1(12) 475150 47150
Punjab 2(22) 110975 221950 2(20) 89700 179400 19(30) 132250 2512750
Sikkim 1(10) 47150 47150 combined 0 0 1(24) 110975 110975

53
State
No of district
level courses*
Cost of
district
level
courses
Total cost-
district
level
SD level
courses
Cost of
Sub-
district
level
courses
Total cost-
SD level
No. of
CHC/PHC
courses
Cost of
CHC/PHC
level courses
Total cost
Tamil Nadu 3(20) 89700 269100 8(30) 132250 1058000 59(30) 132250 7802750
Telengana 1(14) 68425 68425 1(31) 132250 132250 26(30) 132250 3438500
Tripura 1(12) 47150 47150 1(11) 47150 47150 4(30) 132250 529000
Uttarakhand 2(20) 89700 179400 1(17) 89700 89700 11(30) 132250 1454750
West Bengal 2(22) 110975 221950 2(20) 89700 179400 42(30) 132250 5554500
UP 11(20) 89700 986700 combined 0 0 116(30) 132250 15341000
Bihar 4(20) 89700 358800 2(22) 110975 221950 105(30) 132250 13886250
MP 5(20) 89700 448500 3(22) 110975 332925 42(30) 132250 5554500
Rajasthan 5(15) 68425 342125 1(19) 89700 89700 74(30) 132250 9786500
Jharkhand 3(15) 68425 205275 1(10) 47150 47150 19(30) 132250 2512750
Chhattisgarh 3(20) 89700 269100 1(10) 47150 47150 33(30) 132250 4364250
Assam 1(19) 89700 89700 combined 0 0 142(30) 132250 18779500
Total 6410100 4703500 135895542
*Each district team will have 2 including sister tutor of ANMTC

54
Table B.5: LHV and ANM courses required and their cost (Rs.)
State
LHV
courses
No of
participants in
each course
Cost per LHV
course
Total cost
ANM
courses
No of participants
in each course
Cost per
ANM
course
Total cost
Andaman & Nicobar 1 20 56350 1127000 3 30 97750 2932500
Andhra Pradesh 102 30 97750 2932500 256 30 97750 2932500
Chandigarh 1 3 combined with ANM 1 19 56350 1070650
Daman & Diu 0 1 26 97750 2541500
Delhi 1 8 30475 243800 1 27 97750 2639250
Dadar & Nagar 0 2 28 97750 2737000
Goa 0 7 30 97750 2932500
Gujarat 34 30 97750 2932500 269 30 97750 2932500
Haryana 10 30 97750 2932500 86 30 97750 2932500
Jammu & Kashmir 4 30 97750 2932500 76 30 97750 2932500
Karnataka 35 30 97750 2932500 309 30 97750 2932500
Kerala 0 30 97750 2932500 153 30 97750 2932500
Meghalaya 3 30 97750 2932500 14 30 97750 2932500
Maharashtra 60 30 97750 2932500 353 30 97750 2932500
Manipur 2 30 97750 2932500 14 30 97750 2932500
Mizoram 1 30 97750 2932500 12 30 97750 2932500
Nagaland 1 30 97750 2932500 13 30 97750 2932500
Odisha 27 30 97750 2932500 223 30 97750 2932500
Lakshdeep 0 0 1 14 51175 716450
Pondicherry 0 0 2 27 97750 2639250
Punjab 16 30 97750 2932500 98 30 97750 2932500
Sikkim 1 30 97750 2932500 5 30 97750 2932500
Tamil Nadu 33 30 97750 2932500 290 30 97750 2932500

55
State
LHV
courses
No of
participants in
each course
Cost per LHV
course
Total cost
ANM
courses
No of participants
in each course
Cost per
ANM
course
Total cost
Telengana 31 30 97750 2932500 162 30 97750 2932500
Tripura 0 0 0 34 30 97750 2932500
Uttarakhand 5 0 62 30 97750 2932500
West Bengal 4 0 345 30 97750 2932500
UP 64 30 97750 2932500 684 30 97750 2932500
Bihar 3 30 97750 2932500 324 30 97750 2932500
MP 44 30 97750 2932500 306 30 97750 2932500
Rajasthan 37 30 97750 2932500 480 30 97750 2932500
Jharkhand 1 19 56350 1070650 132 30 97750 2932500
Chhattisgarh 19 30 97750 2932500 173 30 97750 2932500
Assam 10 30 97750 2932500 154 30 97750 2932500
Total 70071800 100319100

Funding Projections to Introduce Three New Family Planning Methods in India

Funding Projections to Introduce Three New Family Planning Methods in India

Recommended

Recommended

More Related Content

What's hot

What's hot (16)

Similar to Funding Projections to Introduce Three New Family Planning Methods in India

Similar to Funding Projections to Introduce Three New Family Planning Methods in India (20)

More from HFG Project

More from HFG Project (20)

Recently uploaded

Recently uploaded (20)

Funding Projections to Introduce Three New Family Planning Methods in India